Next Article in Journal
An Immunobridging Study to Evaluate the Neutralizing Antibody Titer in Adults Immunized with Two Doses of Either ChAdOx1-nCov-19 (AstraZeneca) or MVC-COV1901
Next Article in Special Issue
The Frequency and Patterns of Post-COVID-19 Vaccination Syndrome Reveal Initially Mild and Potentially Immunocytopenic Signs in Primarily Young Saudi Women
Previous Article in Journal
Willingness to Receive a COVID-19 Vaccine and Associated Factors among Older Adults: A Cross-Sectional Survey in Shanghai, China
Previous Article in Special Issue
The Side Effects and Adverse Clinical Cases Reported after COVID-19 Immunization
 
 
Systematic Review

Article Versions Notes

Vaccines 2022, 10(5), 653; https://doi.org/10.3390/vaccines10050653
Action Date Notes Link
article xml file uploaded 21 April 2022 10:58 CEST Original file -
article xml uploaded. 21 April 2022 10:58 CEST Update https://www.mdpi.com/2076-393X/10/5/653/xml
article pdf uploaded. 21 April 2022 10:58 CEST Version of Record https://www.mdpi.com/2076-393X/10/5/653/pdf
article html file updated 21 April 2022 10:59 CEST Original file -
article html file updated 2 August 2022 20:00 CEST Update https://www.mdpi.com/2076-393X/10/5/653/html
Back to TopTop